Rtd Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History
Rtd Financial Advisors, Inc.
- $808 Million
- Q4 2025
A detailed history of Rtd Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rtd Financial Advisors, Inc. holds 18,512 shares of BMY stock, worth $866,546. This represents 0.11% of its overall portfolio holdings.
Number of Shares
18,512
Previous 21,602
14.3%
Holding current value
$866,546
Previous $974,000
11.09%
% of portfolio
0.11%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,732Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...